CD74 as a regulator of transcription in normal B cells

Cell Rep. 2022 Nov 1;41(5):111572. doi: 10.1016/j.celrep.2022.111572.

Abstract

CD74 is receptor for the cytokine macrophage migration inhibitory factor (MIF). MIF binding to CD74 induces a signaling cascade resulting in the release of its cytosolic intracellular domain (CD74-ICD) that serves as a transcriptional regulator in chronic lymphocytic leukemia (CLL) cells. In the current study, we investigated the transcriptional and regulatory function of CD74-ICD in normal B cells. We show that following activation, CD74-ICD forms a complex in the cytosol with transcription factors, like PAX5, and binds the chromatin at a significantly higher number of sites compared with its binding in CLL cells. The expression of a major portion of these bound genes is shut down in the malignant cells. The CD74-ICD:PAX5 complex binds the promoter areas of a tumor-suppressor gene, DMTF1, and downregulates its expression through inhibition of transcription. These findings can help identify novel therapeutic pathways that are regulated during oncogenic transformation and are targets for future treatments.

Keywords: B cells; CD74; CLL; CP: Immunology; CP: Molecular biology; DMTF1; MIF; PAX5; chronic lymphocytic leukemia; macrophage migration inhibitory factor; malignant cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • B-Lymphocytes*
  • Histocompatibility Antigens Class II / metabolism
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
  • Protein Binding
  • Signal Transduction
  • Transcription Factors / metabolism
  • Transcription, Genetic

Substances

  • DMTF1 protein, human
  • Histocompatibility Antigens Class II
  • Transcription Factors